Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains Supply Disruption — Glenmark Pharmaceuticals Inc.
Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains Supply Disruption — Glenmark Pharmaceuticals Inc. is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains; Manufacturer: Glenm
| Drug name | Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains |
|---|---|
| Manufacturer | Glenmark Pharmaceuticals Inc., USA |
| Recall/Disruption reason | Lack of Assurance of Sterility |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0820-2021 |
| Initiation date | 20210827 |
| Quantity affected | 28658 cartons |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →